Shannon Thyme Klinger Moderna, Inc. (MRNA) insider trading activity

Shannon Thyme Klinger is Chief Legal Officer of Moderna, Inc.. Currently has a direct ownership of 28,170 shares of MRNA, which is worth approximately $672,699. The most recent transaction as insider was on Aug 29, 2025, when has been sold 113 shares (Common Stock) at a price of $24.47 per share, resulting in proceeds of $2,765. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.2K

2.5% 3M change

55.17% 12M change

Total Value Held $672,699

Shannon Thyme Klinger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 29 2025	SELL Payment of exercise price or tax liability	$2,765 $24.47 p/Share	113 Reduced 0.4%	28,170 Common Stock
Aug 29 2025	BUY Exercise of conversion of derivative security	-	232 Added 0.81%	28,283 Common Stock
Aug 28 2025	SELL Payment of exercise price or tax liability	$4,016 $25.1 p/Share	160 Reduced 0.57%	28,051 Common Stock
Aug 28 2025	BUY Exercise of conversion of derivative security	-	329 Added 1.15%	28,211 Common Stock
Aug 27 2025	SELL Payment of exercise price or tax liability	$9,273 $24.73 p/Share	375 Reduced 1.33%	27,882 Common Stock
Aug 27 2025	BUY Exercise of conversion of derivative security	-	774 Added 2.67%	28,257 Common Stock
Jun 06 2025	SELL Payment of exercise price or tax liability	$14,392 $26.12 p/Share	551 Reduced 1.97%	27,483 Common Stock
Jun 06 2025	BUY Exercise of conversion of derivative security	-	1,139 Added 3.9%	28,034 Common Stock
May 30 2025	SELL Payment of exercise price or tax liability	$3,043 $26.93 p/Share	113 Reduced 0.43%	26,300 Common Stock
May 30 2025	BUY Exercise of conversion of derivative security	-	233 Added 0.87%	26,413 Common Stock
May 28 2025	SELL Payment of exercise price or tax liability	$4,254 $26.76 p/Share	159 Reduced 0.6%	26,180 Common Stock
May 28 2025	BUY Exercise of conversion of derivative security	-	328 Added 1.23%	26,339 Common Stock
May 27 2025	SELL Payment of exercise price or tax liability	$9,821 $26.26 p/Share	374 Reduced 1.42%	26,011 Common Stock
May 27 2025	BUY Exercise of conversion of derivative security	-	773 Added 2.85%	26,385 Common Stock
Mar 07 2025	SELL Payment of exercise price or tax liability	$18,899 $34.3 p/Share	551 Reduced 2.11%	25,612 Common Stock
Mar 07 2025	BUY Exercise of conversion of derivative security	-	1,139 Added 4.17%	26,163 Common Stock
Feb 28 2025	SELL Payment of exercise price or tax liability	$8,487 $31.09 p/Share	273 Reduced 1.08%	25,024 Common Stock
Feb 28 2025	BUY Exercise of conversion of derivative security	-	562 Added 2.18%	25,184 Common Stock
Feb 27 2025	SELL Payment of exercise price or tax liability	$93,318 $33.58 p/Share	2,779 Reduced 10.1%	24,735 Common Stock
Feb 27 2025	BUY Exercise of conversion of derivative security	-	5,747 Added 18.09%	26,018 Common Stock
Feb 12 2025	SELL Payment of exercise price or tax liability	$33,033 $30.93 p/Share	1,068 Reduced 4.75%	21,425 Common Stock
Feb 12 2025	BUY Grant, award, or other acquisition	-	2,047 Added 8.34%	22,493 Common Stock
Dec 09 2024	SELL Open market or private sale	$23,635 $44.68 p/Share	529 Reduced 2.52%	20,446 Common Stock
Dec 06 2024	BUY Exercise of conversion of derivative security	-	1,138 Added 5.15%	20,975 Common Stock
Dec 03 2024	SELL Open market or private sale	$4,849 $43.3 p/Share	112 Reduced 0.56%	19,837 Common Stock

Also insider at

RFL

Rafael Holdings, Inc. Real Estate

Director

STK